Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
BJU International|September 27, 2003
Long-term outcome of antiandrogen monotherapy in advanced prostate carcinoma: 12-year results of a phase II studyV Serretta, G Daricello, N Dispensa, et al.
The Prostate|November 14, 2000
An appraisal of telomerase activity in benign prostatic hyperplasiaE Caldarera, N H Crooks, G H Muir, et al.
Urological Research|April 21, 1976
Permeability of the bladder mucosa to thiotepa, adriamycin, and daunomycin in men and rabbitsM Pavone-Macaluso, N Gebbia, F Biondo, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1993
Current views on intravesical treatment and chemoprophylaxis of superficial bladder cancer. The present role of epirubicin and doxorubicinM Pavone-Macaluso, M Tripi, G B Ingargiola, et al.
Urological Research|January 1, 1992
Soluble and nuclear type I and II androgen-binding sites in benign hyperplasia and cancer of the human prostateL Castagnetta, G Carruba, E Fecarotta, et al.
Urologia Internationalis|January 1, 1991
Natural beta-interferon and androgen receptors in prostatic cancer cellsG Sica, L Fabbroni, G Dell'Acqua, et al.
Pageof 13